type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security amended table style margin margin bottom font size font family time roman align center collaboration exclusive license agreement style margin margin bottom text indent font size font family time roman this collaboration exclusive license agreement agreement effective march nbsp effective date made between nbsp anaptysbio delaware corporation having place business pacific center court suite diego california anaptysbio nbsp tesaro delaware corporation having place business winter street suite waltham massachusetts tesaro tesaro development bermuda corporation having principal office clarendon house church street hamilton bermuda together with tesaro tesaro style margin margin bottom font size font family time roman align center background style margin margin bottom text indent font size font family time roman anaptysbio skill expertise proprietary technology discovery generation optimization immunotherapy antibody style margin margin bottom text indent font size font family time roman anaptysbio developing therapeutic antibody against immune checkpoint protein treatment cancer related condition style margin margin bottom text indent font size font family time roman tesaro posse expertise research development manufacturing commercialization treatment cancer related condition style margin margin bottom text indent font size font family time roman tesaro anaptysbio desire enter collaboration wherein anaptysbio will perform certain discovery early development therapeutic antibody against immune checkpoint protein with goal generating immunotherapy antibody such target subsequent preclinical clinical regulatory commercial development tesaro style margin margin bottom text indent font size font family time roman therefore consideration covenant condition undertaking hereinafter forth agreed between party follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition table style margin margin bottom text indent font size font family time roman used herein following term will have meaning forth below style margin margin bottom text indent font size font family time roman affiliate shall mean corporation other entity whether jure facto which directly indirectly controlling controlled under common control party hereto long such control exists purpose this section nbsp control shall mean direct indirect ownership least fifty percent nbsp outstanding share other voting right subject entity having power vote meeting preceding style page break before always size style color width align center style margin margin bottom font size font family time roman maximum voting right that held particular party under country where such entity exists power otherwise direct affair entity style margin margin bottom text indent font size font family time roman anaptysbio right shall mean collectively anaptysbio patent anaptysbio know style margin margin bottom text indent font size font family time roman anaptysbio know shall mean trade secret other proprietary know right data information composition other technology including limited formula procedure protocol technique result experimentation testing which necessary useful tesaro make develop sell seek regulatory approval market product practice method process which nbsp anaptysbio discloses make available tesaro under this agreement nbsp within control anaptysbio anaptysbio know shall exclude anaptysbio platform style margin margin bottom text indent font size font family time roman anaptysbio patent shall mean patent owned controlled anaptysbio extent claiming manufacture composition development antibody anaptysbio patent shall exclude patent included within anaptysbio platform style margin margin bottom text indent font size font family time roman anaptysbio platform shall mean nbsp know trade secret data invention proprietary software work authorship design technique method process formulation structure other information relating compound composition specification reagent idea information relating anaptysbio proprietary technology that each case generally applicable discovery modification optimization humanization antibody other protein nucleic acid relating thereto including without limitation expression manufacture formulation foregoing nbsp patent other intellectual property right foregoing provided that anaptysbio platform shall include patent covering composition matter whole part development antibody patent forth schedule without limiting generality foregoing anaptysbio platform shall include such information generated discovered developed whole part employee agent anaptysbio performing discovery program otherwise generated discovered developed whole part employee agent anaptysbio during term this agreement each case extent foregoing nbsp relate anaptysbio platform improvement anaptysbio platform anaptysbio platform such anaptysbio platform improvement nbsp generally applicable discovery modification optimization humanization protein nucleic acid including without limitation expression manufacture thereof provided that anaptysbio platform shall include patent covering composition matter whole part development antibody patent forth schedule style margin margin bottom text indent font size font family time roman collaboration right shall mean collaboration patent collaboration know style margin margin bottom text indent font size font family time roman collaboration know shall mean proprietary idea invention data instruction process formula expert opinion information including without limitation biological chemical pharmacological toxicological pharmaceutical physical analytical clinical safety manufacturing quality control data information developed solely style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman jointly anaptysbio tesaro during connection with discovery program tesaro affiliate sublicensees connection with further development product during connection with discovery program collaboration know shall exclude anaptysbio platform style margin margin bottom text indent font size font family time roman collaboration patent shall mean patent subject which invention conceived reduced practice solely jointly anaptysbio tesaro during connection with discovery program tesaro affiliate sublicensees connection with further development product during connection with discovery program collaboration patent shall exclude anaptysbio platform style margin margin bottom text indent font size font family time roman combination product mean product that contains development antibody least other therapeutically active product pharmaceutical ingredient which development antibody style margin margin bottom text indent font size font family time roman commercially reasonable effort mean with respect party such effort that consistent with effort resource normally used such party exercise reasonable business discretion relating research development commercialization pharmaceutical biologic product owned which exclusive right with similar product characteristic which similar market potential similar stage development product life taking into account issue patent coverage safety efficacy product profile competitiveness marketplace proprietary position compound product regulatory structure involved potential actual profitability applicable product including pricing reimbursement status achieved achieved other relevant factor including technical legal scientific medical factor purpose clarity commercially reasonable effort would determined market market indication indication basis particular product anticipated that level effort different different market change over time reflecting change status product market involved style margin margin bottom text indent font size font family time roman confidential information shall have meaning forth section style margin margin bottom text indent font size font family time roman control control controlled controlling shall mean possession ability grant license sublicenses provided herein without violating term agreement other arrangement with third party style margin margin bottom text indent font size font family time roman development antibody shall mean antibody that developed using anaptysbio platform antibody technology under discovery program target antagonist addition antibody existing effective date identified exhibit attached supplmental information package which exhibit also forth sequence such antibody shall each development antibody under this agreement style margin margin bottom text indent font size font family time roman development program shall mean collectively development program development program development program development program shall mean such program style margin margin bottom text indent font size font family time roman discovery plan shall mean written research plan governing joint effort party conducting applicable discovery program which amended from style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom font size font family time roman time time accordance with this agreement initial discovery plan each discovery program attached supplemental information package exhibit style margin margin bottom text indent font size font family time roman discovery program shall mean collectively discovery program discovery program discovery program discovery program shall mean such program style margin margin bottom text indent font size font family time roman discovery program term shall mean with respect discovery program term such discovery program provided section nbsp below style margin margin bottom text indent font size font family time roman shall mean european agency evaluation medicinal product european union successor thereto style margin margin bottom text indent font size font family time roman shall mean food drug administration united state successor thereto style margin margin bottom text indent font size font family time roman field shall mean product purpose including style margin margin bottom text indent font size font family time roman shall mean full time person working discovery program case than full time dedicated person full time equivalent person year based upon total hour year work connection with discovery program style margin margin bottom text indent font size font family time roman study shall mean vitro vivo study that nbsp required under governed under principle good laboratory practice nbsp performed vendor style margin margin bottom text indent font size font family time roman shall mean investigational drug application filed with more fully defined style margin margin bottom text indent font size font family time roman joint steering committee shall have meaning forth section style margin margin bottom text indent font size font family time roman shall mean lymphocyte activation gene encoded gene also known style margin margin bottom text indent font size font family time roman development program shall mean development program conducted accordance with section nbsp development development antibody generated under discovery program style margin margin bottom text indent font size font family time roman discovery program shall mean discovery program conducted accordance with section nbsp development antibody directed antagonize including dual reactive antibody that directed antagonize both style margin margin bottom text indent font size font family time roman mean marketing authorization application similar application marketing approval product field submitted style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman shall mean drug application biologics license application similar application marketing approval product field submitted style margin margin bottom text indent font size font family time roman sale mean with respect product gross invoiced sale price such product sold tesaro affiliate sublicensees selling party length sale third party deduction allowed third party customer selling party extent actually taken third party customer such sale style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman maximum allowed deduction resulting from clause collectively shall exceed percent total sale style margin margin bottom font size font family time roman product sold part combination product purpose determining payment hereunder sale such product shall deemed amount equal following style margin margin bottom margin left font size font family time roman divided multiplied style margin margin bottom margin left font size font family time roman where average sale price during applicable reporting period achieved relevant product country which such sale occurred when product contains only product other active pharmaceutical ingredient style margin margin bottom margin left font size font family time roman average sale price during applicable reporting period achieved that country applicable each active pharmaceutical ingredient included combination product when such compound sold separate product part combination product style margin margin bottom margin left font size font family time roman single price which relevant combination product actually sold style margin margin bottom text indent font size font family time roman event that separate sale either nbsp product other active pharmaceutical ingredient nbsp other active pharmaceutical ingredient combination product made during accounting period which sale made price particular therapeutically active ingredient relevant product otherwise determined accounting period sale allocable product shall determined mutual agreement reached good faith party prior accounting period question based equitable method determining same that take into account variation potency relative contribution each therapeutically active ingredient combination product relative value user each therapeutically active ingredient style margin margin bottom text indent font size font family time roman sale among tesaro affiliate sublicensees shall excluded from computation sale royalty will payable such sale except where such affiliate sublicensees user provided however that subsequent resale third party shall included within sale style margin margin bottom text indent font size font family time roman notwithstanding foregoing sale shall calculated accounted accordance with united state generally accepted accounting principle gaap provided that tesaro should change accounting standard during term this agreement style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom font size font family time roman merger acquisition requirement applicable then sale hereunder calculated accounted accordance with such different accounting standard consistently applied following such change style margin margin bottom text indent font size font family time roman party party shall mean respectively anaptysbio tesaro individually anaptysbio tesaro collectively style margin margin bottom text indent font size font family time roman patent shall mean nbsp patent patent application country supranational jurisdiction territory nbsp substitution division continuation continuation part provisional application reissue renewal registration confirmation examination extension supplementary protection certificate like such patent patent application style margin margin bottom text indent font size font family time roman shall mean programmed cell death protein encoded pdcd gene also known style margin margin bottom text indent font size font family time roman development program shall mean development program conducted accordance with section nbsp development development antibody generated under discovery program style margin margin bottom text indent font size font family time roman discovery program shall mean discovery program conducted accordance with section nbsp development antibody directed antagonize including antibody identified exhibit supplemental information package style margin margin bottom text indent font size font family time roman phase clinical trial shall mean human clinical trial country that intended initially evaluate effectiveness product particular indication indication patient with disease indication under study would satisfy requirement foreign equivalent style margin margin bottom text indent font size font family time roman phase clinical trial shall mean human clinical trial country result which could used establish safety efficacy product basis would satisfy requirement foreign equivalent style margin margin bottom text indent font size font family time roman product shall mean pharmaceutical biologic product therapy including more development antibody whole part active ingredient style margin margin bottom text indent font size font family time roman subcontractor mean third party which party engaged perform service connection with such party fulfilling obligation exercising right under pursuant this agreement style margin margin bottom text indent font size font family time roman supplemental information package mean supplemental information package delivered connection with execution this agreement party effective date style margin margin bottom text indent font size font family time roman target shall mean style margin margin bottom text indent font size font family time roman target antagonist shall mean antibody that created against selected order antagonize target anatagonize that target style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman territory shall mean worldwide style margin margin bottom text indent font size font family time roman tesaro know shall mean proprietary idea invention data instruction process formula expert opinion information including without limitation biological chemical pharmacological toxicological pharmaceutical physical analytical clinical safety manufacturing quality control data information developed tesaro affiliate sublicensees connection with further development product controlled tesaro style margin margin bottom text indent font size font family time roman tesaro patent shall mean patent controlled tesaro subject which invention conceived reduced practice tesaro affiliate sublicensees connection with further development product style margin margin bottom text indent font size font family time roman shall mean cell immunoglobulin mucin protein protein encoded gene style margin margin bottom text indent font size font family time roman development program shall mean development program conducted accordance with section nbsp development development antibody generated under discovery program style margin margin bottom text indent font size font family time roman discovery program shall mean discovery program conducted accordance with section nbsp development antibody directed antagonize including dual reactive antibody that directed antagonize both style margin margin bottom text indent font size font family time roman third party shall mean person entity other than anaptysbio tesaro their respective affiliate style margin margin bottom text indent font size font family time roman third party license shall mean agreement between anaptysbio affiliate thereof third party under which anaptysbio such affiliate been granted license other right under anaptysbio right with respect anaptysbio platform style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign discovery program table style margin margin bottom text indent font size font family time roman goal goal discovery program discovery development antibody directed applicable target characterization certain testing including certain efficacy pharmacology toxicology study provided that none shall study forth applicable discovery plan such discovery program style margin margin bottom text indent font size font family time roman responsibility anaptysbio shall hold primary responsibility executing each discovery program accordance with each discovery plan anaptysbio shall utilize resource methodology needed with respect anaptysbio platform generate development antibody with respect each target style margin margin bottom text indent font size font family time roman conduct discovery program subject term condition forth herein anaptysbio agrees conduct research under discovery program which shall funded forth section nbsp during each discovery program term anaptysbio shall commercially reasonable effort conduct each discovery program accordance with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman applicable discovery plan within time schedule contemplated therein keep tesaro informed progress result discovery program hereunder style margin margin bottom text indent font size font family time roman discovery plan each discovery program shall carried accordance with mutually agreed upon written discovery plan which shall establish specific research objective research task performed resource provided anaptysbio initial discovery plan attached supplemental information package exhibit establish nbsp scope research activity which will performed under applicable discovery program nbsp research objective work plan activity with respect such discovery program nbsp criterion determining when development antibody shall advanced into respective development program discovery plan amended modified from time time approval style margin margin bottom text indent font size font family time roman discovery budget each discovery plan includes budget covering activity conducted anaptysbio under such discovery plan approved party each discovery budget discovery budget amended from time time approval unless otherwise decided only following approved modification applicable discovery plan which necessitates change applicable discovery budget time discovery budget shall reflect party good faith estimate cost reasonably necessary order anaptysbio complete activity forth discovery plan style margin margin bottom text indent font size font family time roman discovery program cost during applicable discovery program term subject tesaro funding cost each discovery program pursuant section nbsp anaptysbio shall beginning each calendar quarter style margin margin bottom text indent font size font family time roman term discovery program each discovery program term shall commence effective date shall upon earlier style margin margin bottom text indent font size font family time roman third party license event that party agree acquire additional technology equipment other fixed asset from third party specifically conduct discovery program tesaro will responsible payment amount third party license intellectual property which directly applies target cost negotiating preparing executing such license style margin margin bottom text indent font size font family time roman record inspection style margin margin bottom text indent font size font family time roman record anaptysbio tesaro shall maintain record each discovery program cause such record maintained sufficient detail good scientific manner will properly reflect work done result achieved performance discovery program including data form required under applicable governmental regulation directed such record shall owned anaptysbio licensed tesaro discovery program discovery program basis accordance with section nbsp anaptysbio shall deliver copy such record tesaro upon tesaro written request anaptysbio shall maintain such record extent delivered tesaro during applicable discovery program term style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom font size font family time roman period least five nbsp year thereafter shall provide tesaro access such record anaptysbio place business upon reasonable advance notice tesaro style margin margin bottom text indent font size font family time roman report information exchange during each discovery program term each tesaro anaptysbio shall their respective commercially reasonable effort disclose other party material information relating applicable discovery program promptly after learned materiality appreciated each party shall also keep other party including joint steering committee informed progress under each discovery plan style margin margin bottom text indent font size font family time roman technology transfer time after cessation termination completion applicable discovery program reasonably requested tesaro time after effective date tesaro shall have right request that anaptysbio commence technology transfer tesaro designee tangible embodiment anaptysbio know other information technology reasonably necessary manufacture clinical commercial manufacture product development antibody with respect such discovery program cost technology transfer shall borne tesaro shall based rate forth herein style margin margin bottom text indent font size font family time roman subcontracting style margin margin bottom text indent font size font family time roman anaptysbio right subcontract subject term this agreement anaptysbio shall have right engage affiliate subcontractor perform certain obligation under discovery plan provided that with respect each subcontract nbsp anaptysbio shall notify tesaro writing confidential basis advance including description activity subcontracted identity subcontractor country involved nbsp anaptysbio shall ensure that each subcontractor accepts complies with applicable term condition this agreement anaptysbio shall remain responsible performance subcontractor hereunder nbsp subcontract shall contain royalty bearing license milestone payment obligation each case payable anaptysbio without prior written consent tesaro nbsp such subcontract shall nbsp writing nbsp subject subordinate term condition this agreement nbsp contain term condition which consistent with term condition this agreement nbsp diminish reduce eliminate anaptysbio obligation under this agreement nbsp impose subcontractor applicable obligation under term this agreement including reporting audit inspection confidentiality provision hereunder well provision prohibiting such subcontractor from further sublicensing subcontracting nbsp reasonable effort cause such subcontract assignable tesaro without consent subcontractor notwithstanding foregoing approval will required anaptysbio desire engage subcontractor perform work related chemistry manufacturing control style margin margin bottom text indent font size font family time roman tesaro right subcontract subject term this agreement tesaro shall have right engage affiliate subcontractor perform certain obligation exercise right under this agreement including activity under development program provided that with respect each subcontract nbsp tesaro shall ensure that each subcontractor accepts complies with applicable term style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom font size font family time roman condition this agreement tesaro shall remain responsible performance subcontractor hereunder nbsp such subcontract shall nbsp writing nbsp subject subordinate term condition this agreement nbsp contain term condition which consistent with term condition this agreement nbsp diminish reduce eliminate tesaro obligation under this agreement nbsp impose subcontractor applicable obligation under term this agreement including reporting audit inspection confidentiality provision hereunder nbsp reasonable effort cause such subcontract assignable anaptysbio without consent subcontractor style margin margin bottom text indent font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development program table style margin margin bottom text indent font size font family time roman development program activity following completion each discovery program tesaro shall responsible sole expense conducting development program which shall include without limitation activity including cross reactivity study pilot study enable pharmacology toxicology study manufacturing regulatory filing clinical trial commercialization activity with respect more development antibody under each development program style margin margin bottom text indent font size font family time roman record inspection style margin margin bottom text indent font size font family time roman record tesaro shall maintain record each development program cause such record maintained sufficient detail good scientific manner will properly reflect work done result achieved performance development program including data form required under applicable governmental regulation tesaro shall maintain such record period shall provide anaptysbio access such record tesaro place business upon reasonable advance notice anaptysbio accordance with section style margin margin bottom text indent font size font family time roman report information exchange during performance each development program tesaro shall commercially reasonable effort disclose anaptysbio material information relating applicable development program promptly after learned materiality appreciated tesaro shall also keep anaptysbio informed progress under each development program within sixty nbsp following each calendar quarter development program style margin margin bottom text indent font size font family time roman assistance anaptysbio upon reasonable request tesaro anaptysbio will good faith make available personnel assist tesaro planning monitoring strategy preclinical development manufacturing early clinical development under each development program provided that material expense incurred anaptysbio including ftes utilized reasonable travel expense specialized supply equipment required shall reimbursed tesaro accordance with section nbsp above style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign management table style margin margin bottom text indent font size font family time roman joint steering committee promptly after effective date tesaro anaptysbio will establish committee joint steering committee oversee review recommend direction each discovery program responsibility joint steering committee shall include monitoring reporting progress developing strategy ensuring open frequent exchange between party regarding each discovery program activity party their affiliate subcontractor agent thereunder style margin margin bottom text indent font size font family time roman membership shall include each tesaro anaptysbio each party member selected that party anaptysbio tesaro each replace representative time upon written notice other party from time time establish subcommittee oversee particular project activity such subcommittee will constituted agrees each party member shall senior individual empowered provide timely feedback regarding their party decision matter style margin margin bottom text indent font size font family time roman meeting during each discovery program term shall meet least quarterly agreed party such location party agree will otherwise communicate regularly telephone electronic mail facsimile video conference with consent party other representative anaptysbio tesaro attend meeting nonvoting observer each party shall responsible expense associated with attendance such meeting style margin margin bottom text indent font size font family time roman minute shall keep accurate minute deliberation which shall record proposed decision action recommended taken secretary appointed member shall responsible preparation draft minute record shall time available both anaptysbio tesaro style margin margin bottom text indent font size font family time roman decision making style margin margin bottom text indent font size font family time roman development program meeting during each calendar period commencing with completion applicable discovery program continuing period thereafter then annually after such period upon written request either party tesaro anaptysbio shall meet discus progress each development program review future activity planned tesaro with respect thereto including strategic plan preclinical clinical commercial advancement product under each development program style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license exclusivity table style margin margin bottom text indent font size font family time roman grant style margin margin bottom text indent font size font family time roman subject term condition this agreement anaptysbio hereby grant tesaro affiliate exclusive license with right grant sublicenses through multiple tier under anaptysbio right collaboration right research develop make have made sell offer sale import export product field territory style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman subject term condition this agreement anaptysbio hereby grant tesaro affiliate exclusive license with right grant sublicenses through multiple tier under patent other intellectual property constituting anaptysbio platform research develop make have made sell offer sale import export product field territory necessary tesaro practice license granted under section nbsp provided however that foregoing license grant tesaro limited researching developing making having made selling offering sale importing exporting using development antibody previously generated anaptysbio expressly excludes license right tesaro utilize practice operate anaptysbio platform develop generate materially different antibody style margin margin bottom text indent font size font family time roman implied license only license granted pursuant express term this agreement shall legal force effect other license right shall created implication estoppel otherwise without limiting foregoing product contains active pharmaceutcial ingredient biologic addition development antibody then license granted tesaro under anaptysbio right anaptysbioplatform shall include right research develop make have made sell offer sale import export such other active pharmaceutical ingredient biologic style margin margin bottom text indent font size font family time roman exclusivity style margin margin bottom text indent font size font family time roman except extent required anaptysbio fulfill obligation under this agreement permitted under this agreement with respect each target combination target style margin margin bottom text indent font size font family time roman during exclusivity period except with respect product pursuant this agreement tesaro shall style margin margin bottom text indent font size font family time roman exclusivity described section will apply discovery program development program basis such that discovery program development program terminated reason then target that subject that discovery program development program shall longer subject exclusivity example discovery program terminated then exclusivity shall longer apply alone dual reactivity exclusivity other terminated discovery program development program shall continue style margin margin bottom text indent font size font family time roman notwithstanding foregoing provision this section nbsp event change control defined below anaptysbio anaptysbio affiliate acquires third party business asset interest therein anaptysbio business acquisition provision this section nbsp shall apply active research development program that portion surviving entity affiliate that anaptysbio prior change control anaptysbio business acquisition ongoing immediately prior date such change control anaptysbio business acquisition purpose this section nbsp change control shall mean with respect party merger consolidation sale substantially such party asset similar transaction series transaction result which such party shareholder before such transaction series transaction than fifty percent nbsp total number voting security style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom font size font family time roman surviving entity immediately after such transaction series transaction clarity result such change control party exists wholly owned subsidiary parent then provision this section nbsp shall continue apply such party surviving entity such parent style margin margin bottom text indent font size font family time roman notwithstanding foregoing provision this section nbsp event change control tesaro tesaro affiliate acquires third party business asset interest therein tesaro business acquisition provision this section nbsp shall apply active research development program that portion surviving entity affiliate that tesaro prior change control tesaro business acquisition ongoing immediately prior date such change control tesaro business acquisition style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign payment table style margin margin bottom text indent font size font family time roman upfront payment within nbsp business following effective date tesaro shall anaptysbio creditable refundable license seventeen million dollar style margin margin bottom text indent font size font family time roman discovery program funding tesaro shall reimburse anaptysbio quarterly basis payment creditable against amount section refundable except pursuant section nbsp section nbsp within nbsp each calendar quarter anaptysbio shall provide tesaro with invoice amount owed tesaro under this section nbsp that calendar quarter tesaro shall such amount within thirty nbsp after receipt anaptysbio quarterly invoice amount paid tesaro anaptysbio pursuant this section nbsp shall made accordance with section nbsp with respect withholding other charge style margin margin bottom text indent font size font family time roman upfront payment development program development program basis tesaro shall anaptysbio following payment style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center milestone event valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman initiation first study valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman first clearance valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman initiation first phase clinical trial valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman initiation first phase clinical trial first indication valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman initiation first phase clinical trial second indication valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman filing first first indication valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman filing first second indication valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman filing first first indication valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman filing first second indication valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center milestone event valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center milestone nbsp payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman first approval first indication valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman first approval second indication valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman first approval first indication valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman first approval second indication valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman achievement annual worldwide sale calendar year equal greater than valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman achievement annual worldwide sale calendar year equal greater than valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman achievement annual worldwide sale calendar year equal greater than valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman achievement annual worldwide sale calendar year equal greater than valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size font family time roman used this section nbsp following term have meaning forth below style margin margin bottom text indent font size font family time roman initiation mean with respect study clinical trial administration first dose product first patient enrolled such study trial style margin margin bottom text indent font size font family time roman clearance mean filing clearance without rejection being placed clinical hold style margin margin bottom text indent font size font family time roman indication mean specific disease condition style margin margin bottom text indent font size font family time roman filing mean acceptance filing with applicable regulatory governmental authority style margin margin bottom text indent font size font family time roman approval mean with respect product country jurisdiction approval registration license authorization from regulatory governmental authority country other jurisdiction that necessary market sell such product such country jurisdiction approval shall specifically include approval blas style margin margin bottom text indent font size font family time roman earned royalty style margin margin bottom text indent font size font family time roman with respect sale product resulting from development antibody product product basis tesaro shall anaptysbio royalty sale follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap align center style margin margin bottom font size font family time roman align center worldwide annual sale product style margin margin bottom font size font family time roman align center product product basis during applicable style margin margin bottom border bottom solid width font size font family time roman align center calendar year during royalty term valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center royalty nbsp rate applicable nbsp product bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion than equal valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman portion greater than than equal valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion greater than than equal valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman portion greater than than equal valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion greater than valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty payable under this section nbsp shall paid country country basis from date first commercial sale each product with respect which royalty payment until later nbsp anniversary first commercial sale product such country nbsp expiration date such country last expire patent within anaptysbio patent collaboration patent covering manufacture sale such product such country royalty term avoidance doubt tesaro obligation royalty under this section nbsp imposed only once with respect same unit product notwithstanding such product covered more than valid claim anaptysbio patent collaboration patent style margin margin bottom text indent font size font family time roman tesaro royalty third party country order make sell offer sale import development antibody component product such country then tesaro shall have right credit percent such third party royalty payment against royalty owing anaptysbio under section nbsp with respect sale such product such country provided however that tesaro shall reduce amount royalty owing anaptysbio under section nbsp with respect such product such country than percent royalty that would otherwise under section nbsp with respect such product such country notwithstanding foregoing tesaro such royalty third party that style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign payment record table style margin margin bottom text indent font size font family time roman payment method payment under this agreement shall made from bank located united state bank wire transfer immediately available fund bank account designated anaptysbio payment hereunder shall made dollar event that date payment subject section nbsp saturday sunday national holiday such payment paid following business payment that paid date such payment under this agreement shall bear interest extent permitted applicable rate percent annum calculated number such payment delinquent style margin margin bottom text indent font size font family time roman payment required paid anaptysbio pursuant this agreement shall paid with deduction withholding account other than imposed measured income similar governmental charge style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty payment report royalty payment under this agreement with respect sale product given calendar quarter shall made anaptysbio designee quarterly within following applicable calendar quarter each royalty payment shall accompanied report style margin margin bottom text indent font size font family time roman book record accounting audit each party shall maintain complete accurate book record accordance with gaap which relevant applicable cost expense reimbursed tesaro payment made anaptysbio under this agreement which book record shall sufficient detail verify payment amount party hereunder party requesting audit auditing party shall have right expense more than once calendar year during term this agreement have independent certified public accountant selected auditing party under obligation confidence audit book record other party audited party location where such book record maintained upon reasonable notice which shall than fifteen nbsp business prior written notice during regular business hour sole purpose verifying basis accuracy payment required made under this agreement report communication such accountant with respect such audit shall limited certificate stating whether applicable report made reimbursement other payment submitted during such period accurate inaccurate discrepancy identified shall also indicate amount applicable with respect report nature discrepancy correct information with respect applicable period such accountant shall provide anaptysbio tesaro with copy each such report simultaneously should audit lead discovery discrepancy nbsp auditing party detriment audited party shall auditing party amount discrepancy within thirty nbsp audited party receipt report nbsp audited party detriment audited party applicable credit amount discrepancy against future payment payable auditing party under this agreement there such payment payable then auditing party shall audited party amount discrepancy within thirty nbsp auditing party receipt report additionally event that discrepancy auditing party detriment greater than five percent nbsp amount such audited period then audited party shall reimburse reasonable cost charged such accountant such audit once auditing party conducted audit permitted this section nbsp respect period inspect audited party book record respect such period unless subsequent audit separate reporting period uncovers fraud part audited party that reasonably expected have been occurring during prior audited period clarity however discrepancy identified accountant during course audit party agree upon resolution such discrepancy then auditing party accountant inspect book record extent reasonably relevant resolving such discrepancy notwithstanding anything herein contrary upon expiration three nbsp year following calendar year right audit book record such calendar year shall expire such party shall released from liability accountability with respect payment work performed reflected such book such party such calendar year including clarity with respect calculation royalty payable with respect each such calendar year party shall longer required retain such book record calendar year after expiration third nbsp calendar year following such calendar year style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman blocked currency time legal restriction territory prevent prompt remittance payment with respect sale therein tesaro shall have right option make such payment depositing amount thereof local currency anaptysbio account bank depository territory style margin margin bottom text indent font size font family time roman confidentiality each party shall treat financial information other party that subject review under this section nbsp this agreement including royalty report such other party confidential information style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign diligence reversion table style margin margin bottom text indent font size font family time roman product tesaro shall commercially reasonable effort nbsp fund development each discovery program forth applicable discovery plan until each discovery program reached applicable program decision point forth applicable discovery plan nbsp advance least development antibody with respect each development program nbsp research test develop product nbsp obtain regulatory approval preclinical clinical commercial least product with respect each development program nbsp commercialize product attempt obtain optimum commercial return each product major market throughout world style margin margin bottom text indent font size font family time roman reversion tesaro fails satisfy obligation under section nbsp with respect discovery program development program discontinues development product within discovery program development program then right that discovery program development program including development antibody product data result material collaboration right resulting from such discovery program development program shall revert anaptysbio accordance with section without further obligation tesaro style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign intellectual property table style margin margin bottom text indent font size font family time roman ownership invention disclosure style margin margin bottom text indent font size font family time roman ownership title invention other intellectual property made employee anaptysbio course performing connection with discovery program shall owned anaptysbio title invention other intellectual property made employee tesaro course performing connection with discovery program further development product shall owned tesaro title invention other intellectual property made jointly employee tesaro anaptysbio course performing connection with discovery program shall owned jointly tesaro anaptysbio inventorship invention other intellectual property made pursuant this agreement shall determined accordance with patent united state except expressly provided this agreement neither party shall have obligation account other profit obtain approval other party license exploit patented jointly owned subject matter reason joint ownership thereof each party hereby waif right have under jurisdiction require such consent accounting notwithstanding foregoing anaptysbio shall sole owner anaptysbio platform style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign align right confidential nbsp treatment nbsp requested table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman disclosure invention each party shall promptly disclose other invention made connection with this agreement style margin margin bottom text indent font size font family time roman patent prosecution prior clearance product resulting from discovery program anaptysbio shall responsible tesaro expense nbsp preparing filing prosecuting maintaining patent application patent directed collaboration patent claiming manufacture composition such product nbsp conducting interference examination reissue opposition relating thereto prosecute maintain provided that tesaro financial obligation with respect such interference opposition shall subject anaptysbio obtaining tesaro prior written consent with respect such action associated cost after clearance product resulting from discovery program tesaro shall responsible tesaro expense prosecute maintain applicable collaboration patent party that tasked prosecute maintain shall keep other party informed with respect prosecution issuance collaboration patent provide prompt notice material matter related thereto including upon such party request other party shall reasonably cooperate with assist party tasked prosecute maintain connection with such activity including without limitation making scientist scientific record reasonably available execution such document instrument performance such reasonably necessary order continue filing prosecution maintenance extension thereof style margin margin bottom text indent font size font family time roman enforcement defense style margin margin bottom text indent font size font family time roman each party shall promptly notify other knowledge acquires potential infringement collaboration patent third party style margin margin bottom text indent font size font family time roman patent within collaboration patent infringed third party country territory connection with manufacture sale product same substantially similar product field such country tesaro shall have primary right obligation institute prosecute control action proceeding with respect such infringement such patent counsel choice anaptysbio shall have right expense represented that action counsel choice tesaro fails bring action proceeding within period hundred twenty nbsp after request anaptysbio anaptysbio shall have right bring control such action counsel choice tesaro shall have right represented such action counsel choice expense style margin margin bottom text indent font size font family time roman party brings action proceeding accordance with section nbsp second party agrees joined party plaintiff necessary give first party reasonable assistance authority file prosecute suit cost expense party bringing suit under this section shall borne such party damage other monetary award recovered shall shared follows amount such recovery actually received party controlling such action shall first applied pocket cost such action then nbsp tesaro party that brings such action proceeding then anaptysbio shall paid amount equal royalty that would have been upon sale infringing product such infringing sale been sale product sold style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman under authority tesaro remaining portion such recovery shall paid tesaro nbsp anaptysbio party that brings such action proceeding then remaining portion such recovery shall retained anaptysbio settlement consent judgment other voluntary final disposition suit under this section nbsp entered into without consent party bringing suit neither party shall however have right enter into settlement consent claim effect that patent protection offered under part collaboration patent would materially negatively affected without consent other party such consent unreasonably withheld style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality table style margin margin bottom text indent font size font family time roman confidential information except otherwise expressly provided herein party agree that term this agreement nbsp year thereafter receiving party shall except expressly provided this section nbsp disclose third party confidential information furnished disclosing party hereto pursuant this agreement result discovery program result purpose this section nbsp confidential information shall mean information sample other material which disclosed tangible form marked confidential with other similar designation indicate confidential proprietary nature disclosed orally indicated orally confidential proprietary time such disclosure confirmed writing confidential proprietary within forty five nbsp after such disclosure notwithstanding foregoing confidential information shall include information that established receiving party competent proof that such information style margin margin bottom text indent font size font family time roman already known receiving party other than under obligation confidentiality time disclosure style margin margin bottom text indent font size font family time roman generally available public otherwise part public domain time disclosure receiving party style margin margin bottom text indent font size font family time roman became generally available public otherwise part public domain after disclosure other than through breach this agreement receiving party style margin margin bottom text indent font size font family time roman independently developed receiving party demonstrated documented evidence prepared contemporaneously with such independent development style margin margin bottom text indent font size font family time roman disclosed receiving party other than under obligation confidentiality third party obligation disclosing party disclose such information others style margin margin bottom text indent font size font family time roman permitted disclosure each party hereto disclose confidential information disclosed other party result extent such disclosure reasonably necessary permitted exercise right granted hereunder filing prosecuting patent application prosecuting defending litigation complying with applicable governmental rule regulation court order otherwise submitting information other governmental authority conducting clinical trial making permitted sublicense otherwise exercising license right expressly granted other party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman pursuant term this agreement provided that party required make such disclosure other than pursuant confidentiality agreement will give reasonable advance notice other party such disclosure save extent inappropriate case patent application will reasonable effort secure confidential treatment such information consultation with other party prior disclosure whether through protective order otherwise disclose only minimum necessary comply with such requirement nothing this article shall restrict tesaro from providing development antibody associated related information academic other collaborator conduct clinical clinical study further research development commercialization development antibody style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publicity table style margin margin bottom text indent font size font family time roman nondisclosure term each party hereto agrees disclose term this agreement third party without prior written consent other party hereto which consent shall unreasonably withheld except such party attorney advisor investor potential investor other similarly situated third party need know basis under circumstance that reasonably ensure confidentiality thereof extent required notwithstanding foregoing press release attached supplemental information package exhibit shall jointly released both party promptly following effective date press release attached supplemental information package exhibit shall released anaptysbio promptly following effective date furthermore understood that either party required issue subsequent press release make disclosure required pursuant filing with security exchange commission otherwise relating term this agreement activity hereunder party agree consult with each other reasonably good faith with respect text timing such press release other disclosure required prior issuance thereof provided that party unreasonably withhold delay consent such release disclosure that either party issue such press release make such disclosure determines based advice counsel reasonably necessary comply with regulation appropriate stock market disclosure furthermore anaptysbio shall have right publicly announce press release otherwise occurrence each significant event under term this agreement including receipt each milestone payment reference above provided that anaptysbio consults with tesaro reasonably good faith with respect text timing such public announcement prior issuance thereof provided that confidential information shall disclosed without permission tesaro style margin margin bottom text indent font size font family time roman publication with respect discovery program each party shall submit proposed scientific publication other party that relates directly more development antibody product discloses result discovery program includes confidential information other party least thirty nbsp advance allow that party review such planned public disclosure reviewing party will promptly review such proposed scientific publication make objection that have publication such result confidential information reviewing party contained therein should reviewing party make objection publication such result confidential information then party shall discus advantage disadvantage publishing such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman result confidential information party unable agree whether publish same respective chief executive officer anaptysbio tesaro with respect tesaro president shall reasonably agree extent which publication such result confidential information shall made anaptysbio acknowledges that tesaro enter into agreement with academic other collaborator conduct study with development antibody including combination with other compound case consistent with license right granted hereunder notwithstanding provision this section nbsp contrary tesaro shall required only request such collaborator comply with provision this section nbsp with regard their scientific publication tesaro shall violation this section nbsp result action such collaborator with respect thereto style margin margin bottom text indent font size font family time roman blinded data purpose promoting otherwise highlighting advantage anaptysbio platform anaptysbio disclose cause disclosed third party blinded data relating each discovery program time during subsequent term agreement provided that nbsp neither tesaro target therapeutic area shall identified directly indirectly connection therewith nbsp tesaro shall have opportunity review each such disclosure least thirty nbsp prior release thereof nbsp such disclosure shall include confidential information tesaro style margin margin bottom text indent font size font family time roman permitted disclosure notwithstanding anything contrary contained this agreement confidentiality agreement between party nothing herein therein shall prevent party from disclosing term this agreement such other information party reasonably determines based advice from counsel necessary desirable disclose under applicable regulation legal process whether connection with ongoing disclosure obligation connection with corporate activity otherwise including required rule regulation united state security exchange commission similar regulatory agency country other than united state stock exchange nasdaq connection with presentation disclosure investor potential investor subject customary appropriate confidentiality restriction style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty table style margin margin bottom text indent font size font family time roman tesaro tesaro represents warrant that style margin margin bottom text indent font size font family time roman legal power authority right enter into this agreement fully perform obligation hereunder taken necessary action part authorize execution delivery this agreement performance obligation hereunder style margin margin bottom text indent font size font family time roman this agreement legal valid obligation binding upon enforceable accordance with term except such enforcement limited bankruptcy insolvency other similar affecting creditor generally general principle equity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman performance obligation hereunder conflict with violate breach constitute default require consent under agreement instrument understanding other contractual obligation tesaro style margin margin bottom text indent font size font family time roman government authorization consent approval license exemption filing registration with court governmental authority necessary transaction contemplated this agreement other agreement instrument executed connection herewith performance obligation under this agreement style margin margin bottom text indent font size font family time roman tesaro shall employ subcontractor consultant that employ individual entity debarred subject similar sanction individual entity which subject debarment investigation proceeding similar proceeding convicted crime which individual entity could debarred under section nbsp foreign equivalent been under indictment crime which person entity could debarred under such provision style margin margin bottom text indent font size font family time roman anaptysbio anaptysbio represents warrant that style margin margin bottom text indent font size font family time roman legal power authority right enter into this agreement fully perform obligation hereunder taken necessary action part authorize execution delivery this agreement performance obligation hereunder style margin margin bottom text indent font size font family time roman this agreement legal valid obligation binding upon enforceable accordance with term except such enforcement limited bankruptcy insolvency other similar affecting creditor generally general principle equity style margin margin bottom text indent font size font family time roman performance obligation hereunder conflict with violate breach constitute default require consent under agreement instrument understanding other contractual obligation anaptysbio style margin margin bottom text indent font size font family time roman government authorization consent approval license exemption filing registration with court governmental authority necessary transaction contemplated this agreement other agreement instrument executed connection herewith performance obligation under this agreement style margin margin bottom text indent font size font family time roman anaptysbio control anaptysbio know anaptysbio patent existing effective date style margin margin bottom text indent font size font family time roman anaptysbio right grant right license purport grant tesaro with respect anaptysbio know anaptysbio patent anaptysbio platform under this agreement style margin margin bottom text indent font size font family time roman anaptysbio present knowledge that settled pending threatened claim lawsuit legal proceeding third party against anaptysbio other person alleging that anaptysbio know anaptysbio patent anaptysbio platform style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman misappropriates infringes part whole intellectual property intellectual property right such third party style margin margin bottom text indent font size font family time roman anaptysbio granted right license third party relating anaptysbio know anaptysbio patent anaptysbio platform that would conflict interfere with right license granted purported granted tesaro hereunder style margin margin bottom text indent font size font family time roman schedule attached hereto forth complete accurate list anaptysbio patent effective date indicating owner owner thereof such anaptysbio patent solely owned anaptysbio anaptysbio disclosed tesaro material information received anaptysbio effective date concerning institution interference opposition reexamination reissue revocation nullification official proceeding involving anaptysbio patent patent included anaptysbio platform anywhere territory style margin margin bottom text indent font size font family time roman best anaptysbio knowledge effective date exhibit attached supplemental information package forth complete accurate list target antagonist owned controlled anaptysbio effective date style margin margin bottom text indent font size font family time roman best anaptysbio knowledge effective date tesaro will required obtain license sublicense under third party license tesaro research develop make have made sell offer sale import export product field territory pursuant right license granted under this agreement style margin margin bottom text indent font size font family time roman anaptysbio shall employ subcontractor consultant that employ individual entity debarred subject similar sanction individual entity which subject debarment investigation proceeding similar proceeding convicted crime which individual entity could debarred under section nbsp foreign equivalent been under indictment crime which person entity could debarred under such provision style margin margin bottom text indent font size font family time roman anaptysbio acknowledges that entering into this agreement tesaro relied upon information supplied anaptysbio information which anaptysbio caused supplied tesaro anaptysbio agent representative such information being hereinafter referred collectively product information knowledge anaptysbio effective date product information accurate material respect anaptysbio effective date intentionally omitted furnish tesaro with material information known anaptysbio concerning anaptysbio right anaptysbio platform development antibody transaction contemplated this agreement which would reasonably considered material tesaro decision enter into this agreement undertake commitment obligation forth herein style margin margin bottom text indent font size font family time roman disclaimer tesaro anaptysbio specifically disclaim guarantee that discovery program will successful whole part failure party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman successfully develop product will constitute breach representation warranty other obligation under this agreement except otherwise expressly forth this agreement anaptysbio tesaro make representation extend warranty condition kind either express implied with respect anaptysbio right information disclosed hereunder product including limited warranty merchantability fitness particular purpose noninfringement intellectual property right third party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification table style margin margin bottom text indent font size font family time roman tesaro tesaro agrees indemnify defend hold anaptysbio affiliate their respective director officer employee agent their respective successor heir assigns anaptysbio indemnitees harmless from against loss cost claim damage liability expense including reasonable attorney professional other expense litigation collectively liability arising directly indirectly connection with third party claim suit action demand judgment relating nbsp breach tesaro representation warranty made this agreement nbsp development commercialization product except each case extent such liability result from gross negligence intentional misconduct anaptysbio style margin margin bottom text indent font size font family time roman anaptysbio anaptysbio agrees indemnify defend hold tesaro affiliate their respective director officer employee agent their respective successor heir assigns tesaro indemnitees harmless from against liability arising directly indirectly connection with third party claim suit action demand judgment relating breach anaptysbio representation warranty made this agreement except extent such liability result from gross negligence intentional misconduct tesaro style margin margin bottom text indent font size font family time roman indemnification procedure party that intends claim indemnification indemnitee under this section nbsp shall promptly notify other party indemnitor writing claim complaint suit proceeding cause action with respect which indemnitee intends claim such indemnification purpose this section nbsp each claim indemnitor shall have sole control defense settlement thereof provided that indemnitee shall have right participate expense with counsel choosing defense settlement such claim indemnification obligation party under this section nbsp shall apply amount paid settlement claim such settlement effected without consent indemnitor which consent shall withheld delayed unreasonably failure deliver written notice indemnitor within reasonable time after commencement such claim prejudicial ability defend such action shall relieve such indemnitor liability indemnitee under this section nbsp omission deliver written notice indemnitor shall relieve indemnitor liability indemnitee otherwise than under this section nbsp indemnitee under this section nbsp employee indemnitor request style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman expense shall provide full information reasonable assistance indemnitor legal representative with respect such claim covered this indemnification style margin margin bottom text indent font size font family time roman limitation liability except breach article gross negligence wrongful intentional omission neither tesaro anaptysbio their respective affiliate sublicensees shall liable other party affiliate their sublicensees indirect incidental consequential special reliance punitive damage lost imputed profit whether liability asserted contract tort including negligence strict product liability indemnity contribution irrespective whether that party representative that party been advised otherwise might have anticipated possibility such loss damage provided that this limitation will limit indemnification obligation party under provision article such damage claimed third party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term termination table style margin margin bottom text indent font size font family time roman term unless earlier terminated agreement will continue full force effect product product discovery program discovery program development program development program country country basis until date further payment under section nbsp above style margin margin bottom text indent font size font family time roman termination breach either party this agreement terminate more discovery program development program this agreement event other party hereto shall have materially breached defaulted representation warranty performance obligation hereunder such default shall have continued sixty after written notice thereof provided breaching party breaching party termination shall become effective such sixty period unless breaching party other party behalf cured such breach default prior expiration sixty period provided however case failure amount hereunder such default basis termination business following date that notice such default provided breaching party style margin margin bottom text indent font size font family time roman termination without cause tesaro tesaro terminate this agreement entirety discovery program discovery program development program development program basis without cause upon ninety prior written notice anaptysbio style margin margin bottom text indent font size font family time roman effect breach termination style margin margin bottom text indent font size font family time roman accrued right obligation termination this agreement portion hereof reason shall release either party hereto from liability which time such termination already accrued other party which attributable style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign table style page break before always size style color width align center style margin margin bottom font size font family time roman period prior such termination preclude either party from pursuing right remedy have hereunder equity with respect breach this agreement style margin margin bottom text indent font size font family time roman return material upon termination this agreement entirety tesaro anaptysbio shall promptly return other confidential information other party except copy which retained archival purpose upon termination this agreement discovery program development program tesaro pursuant section nbsp anaptysbio pursuant section nbsp tesaro shall return anaptysbio copy record received tesaro pursuant section nbsp only discovery program development program terminated then those record received tesaro pursuant section nbsp with respect terminated program style margin margin bottom text indent font size font family time roman effect termination agreement tesaro without cause anaptysbio breach tesaro tesaro terminates this agreement entirety without cause pursuant section nbsp anaptysbio terminates this agreement entirety pursuant section nbsp breach tesaro then style margin margin bottom text indent font size font family time roman license right tesaro under section nbsp shall concurrently terminate tesaro affiliate sublicensees shall immediately cease manufacture development commercialization product provided that tesaro affiliate sublicensees distributor shall entitled during twelve nbsp month period immediately following effective date termination finish work progress sell product remaining inventory accordance with term this agreement style margin margin bottom text indent font size font family time roman tesaro hereby grant anaptysbio irrevocable exclusive worldwide license with right grant authorize sublicenses under tesaro interest collaboration right tesaro patent tesaro know make have made sell offer sell import product style margin margin bottom text indent font size font family time roman extent permitted applicable regulatory authority tesaro shall hereby transfer anaptysbio regulatory filing regulatory approval product held tesaro affiliate sublicensees foregoing transfer permitted applicable regulatory authority tesaro hereby permit anaptysbio cross reference rely upon such regulatory approval regulatory filing style margin margin bottom text indent font size font family time roman anaptysbio shall have sole right prosecute maintain solely enforce collaboration right style margin margin bottom text indent font size font family time roman upon anaptysbio request tesaro shall continue going development product mutually agreed upon migration period after termination this agreement migration period during such migration period tesaro shall provide such knowledge transfer other training anaptysbio reasonably necessary anaptysbio continue such activity connection with such transfer tesaro shall subject subsection nbsp above nbsp transfer anaptysbio quantity product manufactured tesaro tesaro control effective date termination nbsp assign anaptysbio agreement with third party with respect development commercialization style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman product extent assignable nbsp continue funding ftes equivalent number ftes being funded upon date notice termination mutually agreed period exceed remaining portion then current calendar quarter full calendar quarter following effective date termination style margin margin bottom text indent font size font family time roman effect termination discovery program anaptysbio terminates discovery program pursuant section nbsp breach tesaro tesaro discontinues discovery program accordance with section nbsp then style margin margin bottom text indent font size font family time roman anaptysbio obligation conduct further activity under applicable discovery program shall terminate effective date such termination style margin margin bottom text indent font size font family time roman license right tesaro under section nbsp product resulting from such discovery program shall concurrently terminate tesaro affiliate sublicensees shall immediately cease manufacture development commercialization such product style margin margin bottom text indent font size font family time roman tesaro hereby grant anaptysbio irrevocable exclusive worldwide license with right grant authorize sublicenses under tesaro interest collaboration right tesaro patent tesaro know make have made sell offer sell import product resulting from such discovery program style margin margin bottom text indent font size font family time roman extent permitted applicable regulatory authority tesaro shall hereby transfer anaptysbio regulatory filing regulatory approval product resulting from such discovery program held tesaro affiliate sublicensees foregoing transfer permitted applicable regulatory authority tesaro hereby permit anaptysbio cross reference rely upon such regulatory approval regulatory filing style margin margin bottom text indent font size font family time roman anaptysbio shall have sole right prosecute maintain solely enforce collaboration right that subject such discovery program style margin margin bottom text indent font size font family time roman upon anaptysbio request tesaro shall continue going development product resulting from such discovery program mutually agreed upon migration period after termination this agreement during such migration period tesaro shall provide such knowledge transfer other training anaptysbio reasonably necessary anaptysbio continue such activity connection with such transfer tesaro shall nbsp transfer anaptysbio quantity product resulting from such discovery program generated tesaro tesaro control effective date termination nbsp assign anaptysbio agreement with third party with respect development commercialization such product extent assignable nbsp continue funding ftes equivalent number ftes being funded upon date notice termination mutually agreed period exceed remaining portion then current calendar quarter full calendar quarter following effective date termination style margin margin bottom text indent font size font family time roman effect termination development program anaptysbio terminates development program pursuant section nbsp breach tesaro tesaro discontinues development program accordance with section nbsp then style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman license right tesaro under section nbsp product resulting from such development program shall concurrently terminate tesaro affiliate sublicensees shall immediately cease manufacture development commercialization such product style margin margin bottom text indent font size font family time roman tesaro hereby grant anaptysbio irrevocable exclusive worldwide license with right grant authorize sublicenses under tesaro interest collaboration right tesaro patent tesaro know make have made sell offer sell import product resulting from such development program style margin margin bottom text indent font size font family time roman extent permitted applicable regulatory authority tesaro shall hereby transfer anaptysbio regulatory filing regulatory approval product resulting from such development program held tesaro affiliate sublicensees foregoing transfer permitted applicable regulatory authority tesaro hereby permit anaptysbio cross reference rely upon such regulatory approval regulatory filing style margin margin bottom text indent font size font family time roman anaptysbio shall have sole right prosecute maintain solely enforce collaboration right that subject such development program style margin margin bottom text indent font size font family time roman upon anaptysbio request tesaro shall continue going development product resulting from such development program mutually agreed upon migration period after termination this agreement during such migration period tesaro shall provide such knowledge transfer other training anaptysbio reasonably necessary anaptysbio continue such activity connection with such transfer tesaro shall nbsp transfer anaptysbio quantity product resulting from such discovery program manufactured tesaro tesaro control effective date termination nbsp assign anaptysbio agreement with third party with respect development commercialization such product extent assignable nbsp continue funding ftes equivalent number ftes being funded upon date notice termination mutually agreed period exceed remaining portion then current calendar quarter nbsp full calendar quarter following effective date termination style margin margin bottom text indent font size font family time roman effect termination tesaro with cause tesaro breach anaptysbio tesaro terminates more discovery program this agreement pursuant section nbsp breach anaptysbio then style margin margin bottom text indent font size font family time roman license right tesaro under section nbsp with respect applicable discovery program development program product shall automatically become perpetual irrevocable provided that payment obligation under section shall continue provided however that tesaro terminated this agreement pursuant anaptysbio uncured material breach article then without limiting other right remedy available tesaro tesaro shall continue make payment anaptysbio under section fifty percent amount forth therein when they become style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign table style page break before always size style color width align center style margin margin bottom text indent font size font family time roman anaptysbio affiliate sublicensees shall immediately cease research development other activity with respect applicable development antibody product resulting from such discovery program style margin margin bottom text indent font size font family time roman extent permitted applicable regulatory authority anaptysbio shall hereby transfer tesaro regulatory filing regulatory approval applicable product resulting from such discovery program held anaptysbio affiliate sublicensees foregoing transfer permitted applicable regulatory authority anaptysbio shall hereby permit tesaro cross reference rely upon such regulatory approval regulatory filing style margin margin bottom text indent font size font family time roman tesaro shall have sole right prosecute maintain solely enforce collaboration right specific such discovery program style margin margin bottom text indent font size font family time roman upon tesaro request anaptysbio shall continue going development under such discovery program applicable product mutually agreed upon migration period after termination this agreement during such migration period anaptysbio shall provide such knowledge transfer other training tesaro designees reasonably necessary tesaro continue such activity connection with such transfer anaptysbio shall transfer tesaro quantity applicable development antibody product manufactured behalf anaptysbio possession control anaptysbio affiliate contractor effective date termination assign tesaro agreement with third party with respect research development commercialization applicable development antibody product style margin margin bottom text indent font size font family time roman expiration upon expiration last expire royalty term product resulting from discovery program development program license right tesaro under section nbsp with respect such discovery program development program product shall automatically become fully paid perpetual irrevocable style margin margin bottom text indent font size font family time roman survival section section shall survive expiration termination this agreement reason style margin margin bottom text indent font size font family time roman termination sole remedy termination sole remedy under this agreement whether termination effected other remedy will remain available except agreed otherwise herein style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miscellaneous table style margin margin bottom text indent font size font family time roman governing this agreement dispute arising from construction performance breach hereof shall governed construed enforced accordance with state delaware without reference conflict principle thereof that would result application other style margin margin bottom text indent font size font family time roman waiver agreed that waiver either party hereto breach default covenant agreement herein forth shall deemed waiver subsequent similar breach default style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman assignment this agreement shall assignable either party third party hereto without written consent other party hereto attempted assignment shall null void notwithstanding foregoing either party assign this agreement without such consent entity that acquires substantially business asset such party which this agreement pertains whether merger reorganization acquisition sale otherwise this agreement shall binding upon accrue benefit permitted assignee such assignee shall agree perform obligation assignor style margin margin bottom text indent font size font family time roman independent contractor relationship party hereto that independent contractor party hereto deemed agent partner joint venturer others purpose result this agreement transaction contemplated thereby style margin margin bottom text indent font size font family time roman compliance with exercising their right under this license party shall fully comply material respect with requirement applicable regulation rule order governmental body having jurisdiction over exercise right under this license including without limitation those applicable discovery development manufacture distribution import export sale product pursuant this agreement style margin margin bottom text indent font size font family time roman notice notice request other communication hereunder shall writing shall personally delivered registered certified mail return receipt requested postage prepaid each case respective address specified below such other address specified writing other party hereto shall deemed have been given upon receipt style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width style font family time roman font size valign nowrap tesaro valign bottom nbsp nbsp valign colspan tesaro style font family time roman font size valign valign bottom nbsp nbsp valign colspan winter street suite style font family time roman font size valign valign bottom nbsp nbsp valign colspan waltham massachusetts style font family time roman font size valign valign bottom nbsp nbsp valign attention valign bottom nbsp nbsp valign leon moulder style font family time roman font size valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign chief executive officer style font family time roman font size valign valign bottom nbsp nbsp valign facsimile valign bottom nbsp nbsp valign style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan style font family time roman font size valign valign bottom nbsp nbsp valign colspan tesaro development style font family time roman font size valign valign bottom nbsp nbsp valign colspan clarendon house style font family time roman font size valign valign bottom nbsp nbsp valign colspan church street style font family time roman font size valign valign bottom nbsp nbsp valign colspan hamilton style font family time roman font size valign valign bottom nbsp nbsp valign colspan bermuda style font family time roman font size valign valign bottom nbsp nbsp valign attention valign bottom nbsp nbsp valign corporate secretary style font size height height colspan style font family time roman font size valign nowrap style margin margin bottom font size font family time roman with nbsp nbsp copy nbsp which nbsp shall style margin margin bottom font size font family time roman nbsp constitute nbsp notice nbsp valign bottom nbsp nbsp valign bottom colspan hogan lovell style font family time roman font size valign valign bottom nbsp nbsp valign colspan international drive suite table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign colspan baltimore style font family time roman font size valign valign bottom nbsp nbsp valign attention valign bottom nbsp nbsp valign asher rubin style font family time roman font size valign valign bottom nbsp nbsp valign facsimile valign bottom nbsp nbsp valign style font size height height colspan style font family time roman font size valign nowrap anaptysbio valign bottom nbsp nbsp valign colspan anaptysbio style font family time roman font size valign valign bottom nbsp nbsp valign colspan pacific center court suite style font family time roman font size valign valign bottom nbsp nbsp valign colspan diego style font family time roman font size valign valign bottom nbsp nbsp valign attention valign bottom nbsp nbsp valign hamza suria chief executive officer style font family time roman font size valign valign bottom nbsp nbsp valign facsimile valign bottom nbsp nbsp valign style font size height height colspan style font family time roman font size valign nowrap style margin margin bottom font size font family time roman with copy which shall style margin margin bottom font size font family time roman constitute notice valign bottom nbsp nbsp valign bottom colspan fenwick nbsp west style font family time roman font size valign valign bottom nbsp nbsp valign colspan second avenue floor style font family time roman font size valign valign bottom nbsp nbsp valign colspan seattle style font family time roman font size valign valign bottom nbsp nbsp valign attention valign bottom nbsp nbsp valign effie toshav style font family time roman font size valign valign bottom nbsp nbsp valign facsimile valign bottom nbsp nbsp valign table style margin margin bottom text indent font size font family time roman severability each party hereby agrees that intend violate public policy statutory common rule regulation treaty decision government agency executive body thereof country community association country should more provision this agreement become invalid party hereto shall substitute mutual consent valid provision such invalid provision which valid provision their economic effect sufficiently similar invalid provision that reasonably assumed that party would have entered into this agreement with such valid provision event party seek avoid material provision this agreement upon assertion that such provision invalid illegal otherwise unenforceable other party shall have right terminate this agreement upon sixty nbsp prior written notice asserting party unless such assertion eliminated cured within such sixty nbsp period such termination shall deemed termination such party breach pursuant section style margin margin bottom text indent font size font family time roman force majeure neither party shall lose right hereunder liable other party damage loss except payment obligation account failure performance defaulting party failure occasioned strike fire earthquake flood lockout embargo governmental order restriction failure supplier other reason where failure perform beyond reasonable control caused negligence intentional conduct misconduct performing party such party exerted reasonable effort avoid remedy such force majeure provided however that event shall party required settle labor dispute disturbance style margin margin bottom text indent font size font family time roman complete agreement this agreement supplemental information package constitute entire agreement both written oral between party with respect subject matter hereof prior agreement respecting subject matter hereof either written oral express implied shall abrogated canceled null void effect amendment change hereof addition hereto shall effective binding either party hereto unless reduced writing executed respective duly authorized representative anaptysbio tesaro tesaro tesaro development shall jointly severally liable obligation tesaro under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman heading caption several section hereof part this agreement included merely convenience reference shall affect meaning interpretation style margin margin bottom text indent font size font family time roman counterpart this agreement executed counterpart each which shall deemed original which together shall deemed same agreement style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party hereto have caused this collaboration exclusive license agreement duly executed their authorized representative delivered duplicate original effective effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan tesaro valign bottom nbsp nbsp valign colspan anaptysbio style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign valign bottom style border bottom solid nbsp nbsp valign style border bottom solid hamza suria style font size height height colspan height colspan height colspan style font family time roman font size valign name valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign name valign bottom style border bottom solid nbsp nbsp valign style border bottom solid hamza suria style font size height height colspan height colspan height colspan style font family time roman font size valign title valign bottom style border bottom solid nbsp nbsp valign style border bottom solid chief executive officer valign bottom nbsp nbsp valign title valign bottom style border bottom solid nbsp nbsp valign style border bottom solid president nbsp style font size height colspan height colspan height colspan style font family time roman font size valign colspan tesaro development valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan style font family time roman font size valign name valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan style font family time roman font size valign title valign bottom style border bottom solid nbsp nbsp valign style border bottom solid chief executive officer valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign table style margin margin bottom font size font family time roman align center signature page collaboration exclusive license agreement style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center anaptysbio patent style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right confidential treatment requested style page break before always size style color width align center style margin margin bottom font size font family time roman align center amendment style margin margin bottom font size font family time roman align center collaboration exclusive license agreement style margin margin bottom text indent font size font family time roman this amendment nbsp collaboration exclusive license agreement this amendment effective november nbsp amendment date entered into made between nbsp anaptysbio delaware corporation having place business pacific center court suite diego california anaptysbio nbsp tesaro delaware corporation having place business winter street suite waltham massachusetts tesaro tesaro development bermuda corporation having principal office clarendon house church street hamilton bermuda together with tesaro tesaro style margin margin bottom text indent font size font family time roman whereas party previously entered into that certain collaboration exclusive license agreement dated march nbsp agreement style margin margin bottom text indent font size font family time roman whereas party wish amend agreement certain respect term condition forth herein style margin margin bottom text indent font size font family time roman therefore capitalized term defined this amendment shall have meaning ascribed agreement party hereby agree follows style margin margin bottom text indent font size font family time roman amendment license within nbsp business following amendment date tesaro shall anaptysbio creditable refundable license million dollar style margin margin bottom text indent font size font family time roman amendment following section agreement hereby amended replaced their entirety follows style margin margin bottom text indent font size font family time roman section nbsp agreement amended following definition style margin margin bottom text indent font size font family time roman shall mean style margin margin bottom text indent font size font family time roman shall mean both shall used with respect development antibody that specifically designed cross react antagonize both style margin margin bottom text indent font size font family time roman development program shall mean development program conducted accordance with section nbsp development development antibody generated under discovery program style margin margin bottom text indent font size font family time roman discovery program shall mean discovery program conducted accordance with section nbsp development antibody directed antagonize both style margin margin bottom text indent font size font family time roman section nbsp definition development program amended development program style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right confidential treatment requested style page break before always size style color width align center style margin margin bottom text indent font size font family time roman section nbsp definition discovery plan amended exhibit supplemental information package style margin margin bottom text indent font size font family time roman section nbsp definition discovery program amended discovery program style margin margin bottom text indent font size font family time roman section nbsp definition target amended include style margin margin bottom text indent font size font family time roman section nbsp hereby amended adding following sentence immediately following section nbsp exhibit supplemental information package hereby added additional discovery program carried accordance with this agreement style margin margin bottom text indent font size font family time roman section nbsp agreement hereby amended adding following sentence immediately following section style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman tesaro shall anaptysbio each milestone payment forth section nbsp license agreement style margin margin bottom text indent font size font family time roman discovery plan discovery plan discovery program shall added supplemental information package exhibit thereto style margin margin bottom text indent font size font family time roman press release disclosure term this amendment subject section nbsp agreement provided that press release attached this amendment appendix shall jointly released both party promptly following amendment date style margin margin bottom text indent font size font family time roman miscellaneous this amendment shall effective purpose amendment date except expressly modified herein agreement shall continue remain full force effect accordance with term this amendment executed counterpart each which shall deemed original together shall deemed same document style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right confidential treatment requested style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party have caused this amendment executed their respective duly authorized representative effective amendment date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan tesaro valign bottom nbsp nbsp valign colspan anaptysbio style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign valign bottom style border bottom solid nbsp nbsp valign style border bottom solid hamza suria style font size height height colspan height colspan height colspan style font family time roman font size valign name valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign name valign bottom style border bottom solid nbsp nbsp valign style border bottom solid hamza suria style font size height height colspan height colspan height colspan style font family time roman font size valign title valign bottom style border bottom solid nbsp nbsp valign style border bottom solid chief executive officer valign bottom nbsp nbsp valign title valign bottom style border bottom solid nbsp nbsp valign style border bottom solid president nbsp style font size height colspan height colspan height colspan style font family time roman font size valign colspan tesaro development valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan style font family time roman font size valign name valign bottom style border bottom solid nbsp nbsp valign style border bottom solid leon moulder valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign style font size height height colspan height colspan height colspan style font family time roman font size valign title valign bottom style border bottom solid nbsp nbsp valign style border bottom solid chief executive officer valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign table style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center press release style page break before always size style color width align center style margin margin bottom font size font family time roman release december style margin margin bottom font size font family time roman align center tesaro anaptysbio expand immuno oncology collaboration include novel bispecific antibody candidate style margin margin bottom font size font family time roman candidate will target undisclosed immune checkpoint style margin margin bottom font size font family time roman anti antibody data presented today aacr conference orlando style margin margin bottom font size font family time roman waltham diego december nbsp tesaro nasdaq tsro oncology focused biopharmaceutical company anaptysbio privately held therapeutic antibody company today announced expansion their immuno oncology collaboration exclusive license agreement include development novel bispecific antibody candidate designed target undisclosed immune checkpoint style margin margin bottom font size font family time roman anaptysbio tesaro first initiated their collaboration march have together focused development monospecific antibody drug candidate targeting dual reactive antibody drug candidate targeting since beginning this partnership investigational drug enabling preclinical study anti antibody candidate have been initiated additional clinical candidate have been identified including lead candidate targeting style margin margin bottom font size font family time roman through collaboration with anaptysbio employing variety approach including monospecific bispecific dual specific antibody address some most validated promising immune checkpoint target said mary lynne hedley president tesaro committed advancing science immuno oncology order potentially transform care patient with cancer team look forward continued collaboration with anaptysbio these program presentation data describing anti antibody candidate aacr conference later today orlando style margin margin bottom font size font family time roman anaptysbio continues focus development therapeutic antibody unmet medical need immuno oncology inflammation fibrosis strategic advantage ability rapidly discover develop therapeutic antibody against emerging biological target using natural somatic hypermutation mechanism encoded within human immune system said hamza suria president anaptysbio pleased expand collaboration with tesaro look forward advancing multiple immuno oncology antibody into clinic style margin margin bottom font size font family time roman under term this expansion tesaro will anaptysbio undisclosed upfront will provide funding cost incurred anaptysbio related development clinical antibody candidate each program within collaboration anaptysbio eligible receive milestone payment certain research development event achieved additional payment achievement certain regulatory submission approval multiple indication anaptysbio will also eligible receive royalty related worldwide sale product developed under collaboration earn certain commercial milestone payment specified level annual worldwide sale attained anaptysbio tesaro will together complete preclinical development antibody candidate with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman tesaro being solely responsible clinical development manufacturing regulatory commercial activity style margin margin bottom font size font family time roman aacr poster presentation detail style margin margin bottom font size font family time roman aacr conference tumor immunology immunotherapy chapter orlando tuesday december nbsp poster session style margin margin bottom font size font family time roman abstract title identification characterization potent anti human antagonist style margin margin bottom font size font family time roman this poster will available following presentation http tesarobio document aacrdec style margin margin bottom font size font family time roman about anaptysbio style margin margin bottom font size font family time roman anaptysbio privately held antibody development company advancing first class program immuno oncology inflammation fibrosis anaptysbio proprietary platform which couple fully human antibody library with vitro somatic hypermutation mammalian cell generate high affinity antibody replicates feature human immune system overcomes limitation prior antibody technology multiple antibody emanating from anaptysbio pipeline currently undergoing enabling study with potentially transformative clinical read during timeframe more information visit anaptysbio style margin margin bottom font size font family time roman about tesaro style margin margin bottom font size font family time roman tesaro oncology focused biopharmaceutical company dedicated improving life cancer patient acquiring developing commercializing safer more effective therapeutic more information visit tesarobio style margin margin bottom font size font family time roman tesaro contact style margin margin bottom font size font family time roman jennifer davis style margin margin bottom font size font family time roman director corporate development nbsp investor relation style margin margin bottom font size font family time roman jdavis tesarobio style margin margin bottom font size font family time roman anaptysbio contact style margin margin bottom font size font family time roman julie rathbun style margin margin bottom font size font family time roman julie rathbuncomm style margin margin bottom font size font family time roman extent that statement contained this press release description historical fact regarding tesaro they forward looking statement reflecting current belief expectation management made pursuant safe harbor provision private security litigation reform word such will expect anticipate estimate intend similar expression well other word expression referencing future event condition circumstance intended identify forward looking statement example forward looking statement contained this press release include among others statement regarding expectation regarding timing both selection clinical candidate from program commencement clinical testing development plan antibody therapeutic candidate individually combination style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman other product product candidate ability form partnership future support overall oncology strategy forward looking statement this release involve substantial risk uncertainty that could cause research clinical development program clinical development program future result performance achievement differ significantly from those expressed implied forward looking statement such risk uncertainty include among others uncertainty inherent research development therapeutic antibody including selection clinical testing manufacturing antibody initiation future clinical trial availability data from ongoing clinical trial expectation regulatory approval other matter that could affect availability commercial potential drug candidate tesaro undertakes obligation update revise forward looking statement further description risk uncertainty that could cause actual result differ from those expressed these forward looking statement well risk relating business company general tesaro annual report form year ended december nbsp quarterly report form quarter ended september nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center amendment style margin margin bottom font size font family time roman align center collaboration exclusive license agreement style margin margin bottom text indent font size font family time roman this amendment nbsp collaboration exclusive license agreement this amendment effective february nbsp amendment date entered into made between nbsp anaptysbio delaware corporation having place business pacific center court suite diego california anaptysbio nbsp tesaro delaware corporation having place business winter street suite waltham massachusetts tesaro tesaro development bermuda corporation having principal office clarendon house church street hamilton bermuda together with tesaro tesaro style margin margin bottom text indent font size font family time roman whereas party previously entered into that certain collaboration exclusive license agreement dated march nbsp agreement style margin margin bottom text indent font size font family time roman whereas party wish amend agreement certain respect term condition forth herein style margin margin bottom text indent font size font family time roman therefore capitalized term defined this amendment shall have meaning ascribed agreement party hereby agree follows style margin margin bottom text indent font size font family time roman section nbsp agreement hereby amended replaced entirety follows style margin margin bottom text indent font size font family time roman term discovery program each discovery program term shall commence effective date shall upon earlier nbsp december nbsp such other date party agree through nbsp decision tesaro discontinue funding activity under such discovery program nbsp mutual decision tesaro anaptysbio cease activity with respect that discovery program style margin margin bottom text indent font size font family time roman this amendment shall effective purpose amendment date except expressly modified herein agreement shall continue remain full force effect accordance with term this amendment executed counterpart each which shall deemed original together shall deemed same document style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party have caused this amendment executed their respective duly authorized representative effective amendment date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size colspan valign valign bottom nbsp valign valign bottom nbsp valign colspan anaptysbio style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp valign style border bottom solid mary lynne hedley valign bottom nbsp valign valign bottom nbsp valign valign bottom style border bottom solid nbsp valign style border bottom solid hamza suria style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign name valign bottom style border bottom solid nbsp valign style border bottom solid mary lynne hedley valign bottom nbsp valign valign bottom nbsp valign name valign bottom style border bottom solid nbsp valign style border bottom solid hamza suria style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign title valign bottom style border bottom solid nbsp valign style border bottom solid president nbsp chief operating officer valign bottom nbsp valign valign bottom nbsp valign title valign bottom style border bottom solid nbsp valign style border bottom solid president style font size height colspan height colspan height colspan height colspan style font family time roman font size valign colspan tesaro development valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign bottom style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp valign style border bottom solid joseph farmer valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign name valign bottom style border bottom solid nbsp valign style border bottom solid joseph farmer valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign title valign bottom style border bottom solid nbsp valign style border bottom solid director vice president valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp valign table body html text document